JP2018531046A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018531046A5 JP2018531046A5 JP2018539237A JP2018539237A JP2018531046A5 JP 2018531046 A5 JP2018531046 A5 JP 2018531046A5 JP 2018539237 A JP2018539237 A JP 2018539237A JP 2018539237 A JP2018539237 A JP 2018539237A JP 2018531046 A5 JP2018531046 A5 JP 2018531046A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- inhibitor
- seq
- composition
- based inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562241535P | 2015-10-14 | 2015-10-14 | |
| US62/241,535 | 2015-10-14 | ||
| US201662331795P | 2016-05-04 | 2016-05-04 | |
| US62/331,795 | 2016-05-04 | ||
| PCT/US2016/057164 WO2017066657A1 (en) | 2015-10-14 | 2016-10-14 | Nucleic acid based tia-1 inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018531046A JP2018531046A (ja) | 2018-10-25 |
| JP2018531046A6 JP2018531046A6 (ja) | 2018-12-13 |
| JP2018531046A5 true JP2018531046A5 (https=) | 2019-11-21 |
Family
ID=57209905
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018539237A Pending JP2018531046A (ja) | 2015-10-14 | 2016-10-14 | 核酸ベースのｔｉａ−１阻害剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20190142860A1 (https=) |
| EP (1) | EP3362564B1 (https=) |
| JP (1) | JP2018531046A (https=) |
| CA (1) | CA3001853A1 (https=) |
| WO (1) | WO2017066657A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019146805A1 (ja) * | 2018-01-29 | 2019-08-01 | 国立大学法人東京医科歯科大学 | 前頭側頭葉変性症治療剤、前頭側頭葉変性症治療剤のスクリーニング方法、及び前頭側頭葉変性症の治療方法 |
| CN113196055B (zh) * | 2018-10-15 | 2025-06-27 | 马克斯·普朗克科学促进协会 | 用于治疗疾病的化合物及其筛选方法 |
| JP2022512877A (ja) | 2018-11-01 | 2022-02-07 | エフ．ホフマン－ラ ロシュ アーゲー | Ｔｉａ１を標的とするアンチセンスオリゴヌクレオチド |
| CN111500694B (zh) * | 2019-01-31 | 2023-02-24 | 中国科学院脑科学与智能技术卓越创新中心 | Baz2b基因作为靶点在缓解衰老中的应用 |
| EP3921650A1 (en) | 2019-02-08 | 2021-12-15 | Dewpoint Therapeutics, Inc. | Methods of characterizing condensate-associated characteristics of compounds and uses thereof |
| JP2022547606A (ja) * | 2019-09-16 | 2022-11-14 | ザ・トラスティーズ・オブ・コランビア・ユニバーシティー・イン・ザ・シティー・オブ・ニューヨーク | Ｔｉａ１を標的としたストレス顆粒形成およびタウ凝集を抑制する化合物の同定 |
| CN114729941A (zh) | 2019-09-18 | 2022-07-08 | 露点治疗公司 | 筛选凝聚物相关特异性的方法及其用途 |
| CN113358617B (zh) * | 2021-06-02 | 2024-03-01 | 重庆大学 | 胞外囊泡富集检测方法 |
| WO2023129531A2 (en) * | 2021-12-27 | 2023-07-06 | Seq Biomarque, Llc. | Methods for diagnosing and/or treating alzheimer's disease |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5798245A (en) * | 1993-10-07 | 1998-08-25 | Dana-Farber Cancer Institute | TIA-1 binding proteins and isolated complementary DNA encoding the same |
| AU2003295600A1 (en) * | 2002-11-14 | 2004-06-15 | Dharmacon, Inc. | Functional and hyperfunctional sirna |
| US7217807B2 (en) * | 2002-11-26 | 2007-05-15 | Rosetta Genomics Ltd | Bioinformatically detectable group of novel HIV regulatory genes and uses thereof |
| JP2014501097A (ja) * | 2009-07-06 | 2014-01-20 | アルナイラム ファーマシューティカルズ， インコーポレイテッド | 生物由来物質の産生を高めるための組成物及び方法 |
| CA2752947A1 (en) * | 2011-06-30 | 2012-12-30 | Benjamin J. Blencowe | Foxp1 splice variants and methods and uses thereof |
-
2016
- 2016-10-14 EP EP16788347.9A patent/EP3362564B1/en active Active
- 2016-10-14 JP JP2018539237A patent/JP2018531046A/ja active Pending
- 2016-10-14 CA CA3001853A patent/CA3001853A1/en not_active Abandoned
- 2016-10-14 WO PCT/US2016/057164 patent/WO2017066657A1/en not_active Ceased
- 2016-10-14 US US15/767,906 patent/US20190142860A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018531046A5 (https=) | ||
| US10774332B2 (en) | Interfering RNA molecules | |
| CN102666856B (zh) | 定向至RhoA靶基因的双链RNA化合物在制造治疗神经性疼痛的药物中的用途 | |
| ES2646097T3 (es) | Composición para inhibir la expresión de genes y sus usos | |
| EP1389637B1 (en) | Blunt-ended interfering RNA molecules | |
| CA2862628C (en) | Rna modulating oligonucleotides with improved characteristics for the treatment of duchenne and becker muscular dystrophy | |
| JP5624474B2 (ja) | オフターゲット効果を極力抑えるとともに、ＲＮＡｉ機構を飽和させない新規なｓｉＲＮＡ構造及びその用途 | |
| JP2016513976A5 (https=) | ||
| TW202006138A (zh) | Fubp1抑制劑用於治療b型肝炎病毒感染之用途 | |
| US20250243483A1 (en) | Oligonucleotides | |
| RU2013135647A (ru) | Фармацевтическая композиция, содержащая l-днк | |
| CN117043340A (zh) | 寡核苷酸 | |
| AU2015264957B2 (en) | Further novel forms of interfering rna molecules | |
| TW202516004A (zh) | 調節ｊａｋ１表現之雙股寡核苷酸 | |
| JP2011050381A (ja) | 新規オリゴヌクレオチド誘導体及びそれから成るＮＦ−κＢデコイ | |
| JP2005514946A5 (https=) |